Oncolytics Biotech Inc.
USD0.85
-0.00 (-0.39%)
CEO
Jared Kelly
IPO Date
2001-10-05
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$0.86
Prev. Close
$0.85
Day Low
$0.80
Day High
$0.90
52W Low
$0.77
52W High
$1.51
Market Cap
$0.09B
Volume
2.93M
| 0 |
| $0.00 |
| 13 Mar 2026 | Parsons James T. | director | P-Purchase | Acquired | 10,000 | $1.03 |
| 13 Mar 2026 | Kelly Jared | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,050 | $0.96 |
| 13 Feb 2026 | Kelly Jared | director, officer: Chief Executive Officer | P-Purchase | Acquired | 29,500 | $0.84 |
| 13 Feb 2026 | Kelly Jared | director, officer: Chief Executive Officer | P-Purchase | Acquired | 5,600 | $0.84 |
| 13 Feb 2026 | Look Kirk | Chief Financial Officer | P-Purchase | Acquired | 12,000 | $0.84 |
| 13 Feb 2026 | Pisano Wayne | director | P-Purchase | Acquired | 30,000 | $0.84 |
| 13 Feb 2026 | Heineman Thomas Charles | Chief Medical Officer | P-Purchase | Acquired | 12,132 | $0.83 |
| 13 Feb 2026 | Brown Deborah Margaret | director | P-Purchase | Acquired | 25,000 | $0.85 |